Vulvar cancer epidemiology and demographics: Difference between revisions

	Vulvar cancer Microchapters
Home
Patient Info
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Vulvar cancer from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging
History and Symptoms
Physical Examination
Laboratory Findings
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Vulvar cancer epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Vulvar cancer epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Vulvar cancer epidemiology and demographics
CDC on Vulvar cancer epidemiology and demographics
Vulvar cancer epidemiology and demographics in the news
Blogs on Vulvar cancer epidemiology and demographics
Directions to Hospitals Treating Vulvar cancer
Risk calculators and risk factors for Vulvar cancer epidemiology and demographics

← Older edit

VisualWikitext

Latest revision as of 19:56, 10 April 2019

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Monalisa Dmello, M.B,B.S., M.D. [2] Syed Musadiq Ali M.B.B.S.[3]

Overview

The incidence of vulvar cancer was estimated to be 2.4 per 100,000 females in the United States. The incidence of vulvar cancer increases with age; the median age at diagnosis is 68 years. Vulvar cancer is more prevalent in the caucasian race.^[1]

Epidemiology and Demographics

Incidence

The overall age adjusted incidence rate of vulvar cancer among females is approximately 2.4 per 100,000 individuals in the United States.^[1]

Age

The incidence of vulvar cancer increases with age; the median age at diagnosis is 68 years.^[1]

Age	<20	20-34	35-44	45-54	55-64	65-74	75-84	>85
Incidence	0.2%	2%	6.1%	15.3%	19.8%	19.8%	22.1%	14.9%

Race

Vulvar cancer is more prevalent in the caucasian race.^[1]

Race	All Races	White	Black	Asian/Pacific Islander	American Indian/Alaska Native	Hispanic	Non-Hispanic
Incidence	2.4 per 100,000	2.6 per 100,000	1.8 per 100,000	0.9 per 100,000	2.0 per 100,000	1.7 per 100,000	2.5 per 100,000

References

↑ ^1.0 ^1.1 ^1.2 ^1.3 SEER Stat Fact Sheets: Vulvar Cancer. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/statfacts/html/vulva.html Accessed on September 21, 2015

[xyz-1] 1.0 ^1.1 ^1.2 ^1.3 SEER Stat Fact Sheets: Vulvar Cancer. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/statfacts/html/vulva.html Accessed on September 21, 2015

[1]

@@ Line 1: / Line 1: @@
 __NOTOC__
 {{Vulvar cancer}}
-{{CMG}}{{AE}}{{MD}}
+{{CMG}}{{AE}}{{MD}} {{sali}}
 ==Overview==
-In 2012, the [[incidence]] of  vulvar cancer was estimated to be 2.4 per 100,000 females in the United States.
+The [[incidence]] of  vulvar cancer was estimated to be 2.4 per 100,000 females in the United States. The [[incidence]] of vulvar cancer increases with age; the median age at diagnosis is 68 years. Vulvar cancer is more prevalent in the caucasian race.<ref name=xyz> SEER Stat Fact Sheets: Vulvar Cancer.  Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/statfacts/html/vulva.html Accessed on September 21, 2015</ref>
+==Epidemiology and Demographics==
 ==Incidence==
-The [[incidence]]  of vulvar cancer was 2.4 per 100,000 women per year. These rates are age-adjusted and based on 2008-2012 cases and deaths.<ref> SEER Stat Fact Sheets: Vulvar Cancer.  Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/statfacts/html/vulva.html Accessed on September 21, 2015</ref>
+The overall age adjusted incidence rate of vulvar cancer among females is approximately 2.4 per 100,000 individuals in the United States.<ref name=xyz> SEER Stat Fact Sheets: Vulvar Cancer.  Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/statfacts/html/vulva.html Accessed on September 21, 2015</ref>
 ==Age==
-*The [[ incidence]] of vulvar cancer increases with age; the median age at diagnosis is 68 years.<ref> SEER Stat Fact Sheets: Vulvar Cancer.  Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/statfacts/html/vulva.html Accessed on September 21, 2015</ref>
+*The [[incidence]] of vulvar cancer increases with age; the median age at diagnosis is 68 years.<ref name=xyz> SEER Stat Fact Sheets: Vulvar Cancer.  Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/statfacts/html/vulva.html Accessed on September 21, 2015</ref>
+{| style="border: 0px; font-size: 90%; margin: 3px; width: 600px" align=center
-{| style="cellpadding=0; cellspacing= 0; width: 600px;"
 |-
-|style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''Age''' || style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''<20''' ||style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''20-34''' || style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''35-44''' || style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''45-54'''  || style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''55-64'''  || style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''65-74''' ||style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''75-84''' || style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''>85'''
+|style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''Age''' || style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''<20''' ||style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''20-34''' || style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''35-44''' || style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''45-54'''  || style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''55-64'''  || style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''65-74''' ||style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''75-84''' || style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''>85'''
 |-
-| style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''Incidence'''|| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |0.2% ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |2% ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |6.1% ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |15.3% ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |19.8% || style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |19.8% ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |22.1% ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |14.9%
+| style="padding: 0 5px; font-size: 100%; background: #4479BA; color:F5F5F5 ; width: 10%" align=center |'''Incidence'''
+|style="font-size: 100; padding: 0 5px; background: #DCDCDC" align=center |0.2%
+|style="font-size: 100; padding: 0 5px; background: #DCDCDC" align=center |2%
+|style="font-size: 100; padding: 0 5px; background: #DCDCDC" align=center |6.1%
+|style="font-size: 100; padding: 0 5px; background: #DCDCDC" align=center |15.3%
+|style="font-size: 100; padding: 0 5px; background: #DCDCDC" align=center |19.8%
+|style="font-size: 100; padding: 0 5px; background: #DCDCDC" align=center |19.8%
+|style="font-size: 100; padding: 0 5px; background: #DCDCDC" align=center |22.1%
+|style="font-size: 100; padding: 0 5px; background: #DCDCDC" align=center |14.9%
 |}
 ==Race==
-* Vulvar cancer is more prevalent in the white race.<ref> SEER Stat Fact Sheets: Vulvar Cancer.  Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/statfacts/html/vulva.html Accessed on September 21, 2015</ref>
+* Vulvar cancer is more prevalent in the caucasian race.<ref name=xyz> SEER Stat Fact Sheets: Vulvar Cancer.  Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/statfacts/html/vulva.html Accessed on September 21, 2015</ref>
-{| style="cellpadding=0; cellspacing= 0; width: 600px;"
+{| style="border: 0px; font-size: 90%; margin: 3px; width: 600px" align=center
 |-
-|style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''Race''' || style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''All Races''' ||style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''White''' || style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''Black''' || style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center | '''Asian/Pacific Islander''' ||style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''American Indian/Alaska Native'''||style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''Hispanic'''||style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''Non-Hispanic'''
+|style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''Race''' || style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''All Races''' ||style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''White''' || style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''Black''' || style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center | '''Asian/Pacific Islander''' ||style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''American Indian/Alaska Native'''||style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''Hispanic'''||style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''Non-Hispanic'''
 |-
-| style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''Incidence'''|| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |2.4 per 100,000 ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |2.6 per 100,000 ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |1.8 per 100,000 ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |0.9 per 100,000 ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |2.0 per 100,000 || style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |1.7 per 100,000 ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |2.5 per 100,000
+| style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''Incidence'''|| style="font-size: 100; padding: 0 5px; background: #DCDCDC" align=center |2.4 per 100,000 ||style="font-size: 100; padding: 0 5px; background: #DCDCDC" align=center |2.6 per 100,000 ||style="font-size: 100; padding: 0 5px; background: #DCDCDC" align=center |1.8 per 100,000 ||style="font-size: 100; padding: 0 5px; background: #DCDCDC" align=center |0.9 per 100,000 ||style="font-size: 100; padding: 0 5px; background: #DCDCDC" align=center |2.0 per 100,000 || style="font-size: 100; padding: 0 5px; background: #DCDCDC" align=center |1.7 per 100,000 ||style="font-size: 100; padding: 0 5px; background: #DCDCDC" align=center |2.5 per 100,000
 |}
 ==References==
-{{Reflist|2}}
+{{Reflist|1}}
 [[Category:Types of cancer]]
+[[Category:Gynecology]]
+ [[Category:Up-To-Date]]
+[[Category:Oncology]]
+[[Category:Medicine]]
 [[Category:Gynecology]]